Related Experiment Videos
Sydenham's chorea: not gone and not forgotten
Daniel J Bonthius1, Bahri Karacay
1Department of Pediatrics, College of Medicine, University of Iowa, Iowa City 52242, USA.
Seminars in Pediatric Neurology
|June 6, 2003
Summary
Sydenham's chorea, a rheumatic fever complication in children, causes movement and psychiatric issues. Antibiotic prophylaxis and immune therapies targeting streptococcal infections and basal ganglia antibodies are key treatments.
Area of Science:
- Neurology
- Pediatrics
- Rheumatology
Background:
- Sydenham's chorea is a neurological disorder linked to rheumatic fever.
- It presents with movement abnormalities and psychiatric symptoms in children globally.
- It can also indicate severe cardiac involvement (carditis).
Observation:
- The condition is triggered by streptococcal pharyngitis.
- Its pathogenesis involves anti-basal ganglia antibodies.
- It may be part of a broader spectrum of streptococcal-induced neuropsychiatric syndromes.
Findings:
- Antibiotic prophylaxis is crucial for preventing recurrent streptococcal infections.
- Therapies aimed at immune modulation or restoring basal ganglia neurotransmitter balance show potential.
- Sydenham's chorea is recognized as a significant pediatric neurological concern.
Implications:
- Early diagnosis and management are vital to prevent long-term complications like carditis.
- Understanding the autoimmune basis may lead to novel therapeutic strategies.
- This highlights the importance of addressing streptococcal infections in pediatric populations.